AU6802801A - Secreted and transmembrane polypeptides and nucleic acids encoding the same - Google Patents
Secreted and transmembrane polypeptides and nucleic acids encoding the sameInfo
- Publication number
- AU6802801A AU6802801A AU6802801A AU6802801A AU6802801A AU 6802801 A AU6802801 A AU 6802801A AU 6802801 A AU6802801 A AU 6802801A AU 6802801 A AU6802801 A AU 6802801A AU 6802801 A AU6802801 A AU 6802801A
- Authority
- AU
- Australia
- Prior art keywords
- secreted
- same
- nucleic acids
- acids encoding
- transmembrane polypeptides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70532—B7 molecules, e.g. CD80, CD86
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (40)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2000/005601 WO2000056889A2 (en) | 1999-03-23 | 2000-03-01 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
PCT/US2000/005841 WO2000053758A2 (en) | 1999-03-08 | 2000-03-02 | Compositions and methods for the treatment of immune related diseases |
US18720200P | 2000-03-03 | 2000-03-03 | |
US18696800P | 2000-03-06 | 2000-03-06 | |
US18932800P | 2000-03-14 | 2000-03-14 | |
US18932000P | 2000-03-14 | 2000-03-14 | |
PCT/US2000/006884 WO2001005972A1 (en) | 1999-07-20 | 2000-03-15 | Compositions and methods for the treatment of immune related diseases |
US19131400P | 2000-03-21 | 2000-03-21 | |
US19082800P | 2000-03-21 | 2000-03-21 | |
US19104800P | 2000-03-21 | 2000-03-21 | |
US19100700P | 2000-03-21 | 2000-03-21 | |
US19265500P | 2000-03-28 | 2000-03-28 | |
US19305300P | 2000-03-29 | 2000-03-29 | |
US19303200P | 2000-03-29 | 2000-03-29 | |
PCT/US2000/008439 WO2000073454A1 (en) | 1999-06-02 | 2000-03-30 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US19464700P | 2000-04-04 | 2000-04-04 | |
US19444900P | 2000-04-04 | 2000-04-04 | |
US19597500P | 2000-04-11 | 2000-04-11 | |
US19618700P | 2000-04-11 | 2000-04-11 | |
US19669000P | 2000-04-11 | 2000-04-11 | |
US19600000P | 2000-04-11 | 2000-04-11 | |
US19682000P | 2000-04-11 | 2000-04-11 | |
US19858500P | 2000-04-18 | 2000-04-18 | |
US19812100P | 2000-04-18 | 2000-04-18 | |
US19965400P | 2000-04-25 | 2000-04-25 | |
US19939700P | 2000-04-25 | 2000-04-25 | |
US19955000P | 2000-04-25 | 2000-04-25 | |
US20151600P | 2000-05-03 | 2000-05-03 | |
PCT/US2000/013705 WO2000073445A2 (en) | 1999-06-02 | 2000-05-17 | Interleukin-1-receptor associated kinase-3 (irak3) |
PCT/US2000/014042 WO2000077037A2 (en) | 1999-06-15 | 2000-05-22 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
PCT/US2000/014941 WO2000073348A2 (en) | 1999-06-02 | 2000-05-30 | Methods and compositions for inhibiting neoplastic cell growth |
PCT/US2000/015264 WO2000073452A2 (en) | 1999-06-02 | 2000-06-02 | Compositions and methods for the treatment of immune related diseases |
US20983200P | 2000-06-05 | 2000-06-05 | |
PCT/US2000/020710 WO2001009327A2 (en) | 1999-07-28 | 2000-07-28 | Method of preventing the injury or death of retinal cells and treating ocular diseases |
US64484800A | 2000-08-22 | 2000-08-22 | |
PCT/US2000/023328 WO2001016318A2 (en) | 1999-09-01 | 2000-08-24 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
PCT/US2000/030952 WO2001049715A2 (en) | 2000-01-06 | 2000-11-08 | Methods and compositions for inhibiting neoplastic cell growth |
PCT/US2000/032678 WO2001040466A2 (en) | 1999-12-01 | 2000-12-01 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
PCT/US2000/034956 WO2001046420A2 (en) | 1999-12-23 | 2000-12-20 | Il-17 and il-17r homologous polypeptides and therapeutic uses thereof |
PCT/US2001/006520 WO2001068848A2 (en) | 2000-03-01 | 2001-02-28 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6802801A true AU6802801A (en) | 2001-09-24 |
Family
ID=40231083
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU6802801A Pending AU6802801A (en) | 2000-03-01 | 2000-11-29 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
AU2001268028A Abandoned AU2001268028A1 (en) | 2000-03-01 | 2001-02-28 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001268028A Abandoned AU2001268028A1 (en) | 2000-03-01 | 2001-02-28 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1259614A2 (enrdf_load_stackoverflow) |
JP (3) | JP2004508805A (enrdf_load_stackoverflow) |
AU (2) | AU6802801A (enrdf_load_stackoverflow) |
CA (10) | CA2534018A1 (enrdf_load_stackoverflow) |
WO (1) | WO2001068848A2 (enrdf_load_stackoverflow) |
Families Citing this family (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7057017B2 (en) | 1997-04-16 | 2006-06-06 | Millennium Pharmaceuticals, Inc. | Human dickkopf-related protein and nucleic acid molecules and uses therefor |
CA2301796A1 (en) | 1997-08-19 | 1999-02-25 | Human Genome Sciences, Inc. | 70 human secreted proteins |
WO1999012963A2 (en) | 1997-09-12 | 1999-03-18 | Biogen, Inc. | Cysteine rich receptors: trail |
US6849719B2 (en) | 1997-09-17 | 2005-02-01 | Human Genome Sciences, Inc. | Antibody to an IL-17 receptor like protein |
EP1015488B1 (en) * | 1997-09-17 | 2009-09-09 | Human Genome Sciences, Inc. | Interleukin-17 receptor-like protein |
US20030039648A1 (en) | 1998-09-16 | 2003-02-27 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
US20030130182A1 (en) * | 1997-11-05 | 2003-07-10 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US7446181B2 (en) | 1998-01-15 | 2008-11-04 | Millennium Pharmaceuticals, Inc. | Antibodies that bind human Dickkopf-1 proteins |
US7771719B1 (en) | 2000-01-11 | 2010-08-10 | Genentech, Inc. | Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E |
IL138930A0 (en) | 1998-05-15 | 2001-11-25 | Genentech Inc | Il-17 homologies polypeptides and therapeutic uses thereof |
US6344541B1 (en) | 1998-09-25 | 2002-02-05 | Amgen Inc. | DKR polypeptides |
US20030187196A1 (en) | 1998-12-30 | 2003-10-02 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US6291663B1 (en) * | 1999-03-03 | 2001-09-18 | Board Of Trustees Of The University Of Arkansas | TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma |
US8133734B2 (en) | 1999-03-16 | 2012-03-13 | Human Genome Sciences, Inc. | Kit comprising an antibody to interleukin 17 receptor-like protein |
HK1044023A1 (zh) * | 1999-05-13 | 2002-10-04 | Medical Research Council | Ox2受体同系物 |
US7034132B2 (en) | 2001-06-04 | 2006-04-25 | Anderson David W | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
EP1637541B1 (en) * | 1999-09-01 | 2010-03-03 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
AU784746B2 (en) | 1999-11-18 | 2006-06-08 | Dendreon Corporation | Nucleic acids encoding endotheliases, endotheliases and uses thereof |
EP1897946B1 (en) * | 1999-12-23 | 2012-07-11 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
US20040043397A1 (en) | 2000-01-11 | 2004-03-04 | Genentech, Inc. | IL-17 homologous polypeptides and therapeutic uses thereof |
WO2002026834A2 (en) * | 2000-09-25 | 2002-04-04 | Millennium Pharmaceuticals Inc. | 32624 a novel human udp-glucuronosyl and glycosyl transferase family member and uses thereof |
US7094566B2 (en) | 2000-03-16 | 2006-08-22 | Amgen Inc., | IL-17 receptor like molecules and uses thereof |
US7718397B2 (en) | 2000-03-21 | 2010-05-18 | Genentech, Inc. | Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof |
WO2001083781A2 (en) * | 2000-04-28 | 2001-11-08 | Millennium Pharmaceuticals, Inc. | 14094, a novel human trypsin family member and uses thereof |
US20030096969A1 (en) | 2000-06-02 | 2003-05-22 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US20030031675A1 (en) | 2000-06-06 | 2003-02-13 | Mikesell Glen E. | B7-related nucleic acids and polypeptides useful for immunomodulation |
ES2300340T3 (es) | 2000-06-06 | 2008-06-16 | Bristol-Myers Squibb Company | Acidos nucleicos y polipeptidos relacionados con b7 y sus usos para inmunomodulacion. |
AU2001268440A1 (en) * | 2000-06-15 | 2002-01-08 | Millennium Pharmaceuticals, Inc. | 53320, a human acyltransferase and uses therefor |
AU7005801A (en) * | 2000-06-22 | 2002-01-02 | Biogen Inc | Gp354 nucleic acids and polypeptides |
US20020061574A1 (en) * | 2000-09-01 | 2002-05-23 | Rachel Meyers | 16658, 14223, and 16002, novel human kinases and uses therefor |
JP2004502417A (ja) * | 2000-06-30 | 2004-01-29 | アムジェン インコーポレーテッド | B7様分子およびその使用 |
AU2001283062A1 (en) | 2000-08-02 | 2002-02-13 | The Johns Hopkins University | Endothelial cell expression patterns |
AU2001229503A1 (en) * | 2000-08-28 | 2002-03-13 | Human Genome Sciences, Inc. | 17 human secreted proteins |
WO2002040654A2 (en) | 2000-11-14 | 2002-05-23 | Bristol-Myers Squibb Company | A human serpin secreted from lymphoid cells lsi-01 |
DE10106835A1 (de) * | 2001-02-14 | 2002-09-05 | Basf Lynx Bioscience Ag | Signaltransduktionsproteine 15B3, 15B3-1 und 15B3-2 und zugrundeliegende DNA-Sequenzen |
JPWO2002064769A1 (ja) * | 2001-02-15 | 2004-06-17 | 塩野義製薬株式会社 | 新規疾患マーカー |
EP1873245A1 (en) * | 2001-02-28 | 2008-01-02 | Genentech, Inc. | Interleukin-8 homologous polypeptides and therapeutic uses thereof |
AU2002257088A1 (en) * | 2001-03-12 | 2002-09-24 | Incyte Genomics, Inc. | Immunoglobulin superfamily proteins |
US7125703B2 (en) | 2001-03-13 | 2006-10-24 | Dendreon Corporation | Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon |
KR20040011480A (ko) | 2001-03-22 | 2004-02-05 | 덴드레온 샌 디에고 엘엘씨 | 세린 프로테아제 cvsp14를 암호화하는 핵산 분자,암호화된 폴리펩티드 및 이에 근거한 방법 |
EP1379637A4 (en) | 2001-03-27 | 2005-04-06 | Dendreon Corp | TRANSMEMBRANE SERINE PROTEASE 9 CODING NUCLEIC ACID MOLECULES, THE POLYPEPTIDE CODED, AND METHODS FORMING THEREOF |
US7033790B2 (en) | 2001-04-03 | 2006-04-25 | Curagen Corporation | Proteins and nucleic acids encoding same |
WO2002083921A2 (en) | 2001-04-10 | 2002-10-24 | Agensys, Inc. | Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers |
WO2002083856A2 (en) | 2001-04-11 | 2002-10-24 | Bristol-Myers Squibb Company | Polynucleotides encoding two novel human g-protein coupled receptors, hgprbmy28 and hgprbmy29, and splice variants thereof |
CA2447050A1 (en) | 2001-05-14 | 2002-11-21 | Dendreon San Diego Llc | Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon |
US7125663B2 (en) | 2001-06-13 | 2006-10-24 | Millenium Pharmaceuticals, Inc. | Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer |
WO2003000021A2 (en) * | 2001-06-22 | 2003-01-03 | Biogen, Inc. | Pancam nucleic acids and polypeptides |
WO2003004530A1 (en) * | 2001-07-06 | 2003-01-16 | Bayer Aktiengesellschaft | Regulation of human somatostatin receptor-like protein |
US20060293225A1 (en) * | 2001-07-26 | 2006-12-28 | Genset S.A. | Gmg-2 polynucleotides and polypeptides and uses thereof |
JP4702819B2 (ja) * | 2001-08-01 | 2011-06-15 | 生化学工業株式会社 | コンドロイチン合成酵素 |
US7262026B2 (en) | 2001-08-23 | 2007-08-28 | Japan Science And Technology Agency | Hematopoietic stem cell proliferation regulators and polynucleotides encoding the same |
AU2002330015B2 (en) | 2001-09-18 | 2008-02-07 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
AU2002333862A1 (en) * | 2001-09-20 | 2003-04-01 | Bayer Aktiengesellschaft | Regulation of human prolyl 4-hydroxylase alpha subunit precursor |
WO2003039462A2 (en) * | 2001-11-02 | 2003-05-15 | Tanox, Inc. | B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
AU2002359815A1 (en) | 2001-12-19 | 2003-07-09 | Immunex Corporation | C-type lectin polypeptide, polynucleotide and methods of making and use thereof |
DE10211088A1 (de) * | 2002-03-13 | 2003-09-25 | Ugur Sahin | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
JP2005523311A (ja) * | 2002-04-17 | 2005-08-04 | ジェネンテック・インコーポレーテッド | 腫瘍の診断と治療のための組成物と方法 |
JP2005527614A (ja) | 2002-05-29 | 2005-09-15 | デヴェロゲン アクチエンゲゼルシャフト フュア エントヴィックルングスビオローギッシェ フォルシュング | 膵臓特異性タンパク質 |
EP1514926A4 (en) * | 2002-05-31 | 2006-01-11 | Hidetoshi Inoko | SLURP-2 GENE ASSOCIATED WITH INFLAMMATORY SKIN DISEASE AND USE THEREOF |
ATE388233T1 (de) * | 2002-05-31 | 2008-03-15 | Seikagaku Kogyo Co Ltd | Chondroitinsynthetase und das enzym codierende nukleinsäure |
EP2305710A3 (en) | 2002-06-03 | 2013-05-29 | Genentech, Inc. | Synthetic antibody phage libraries |
DE10242016A1 (de) * | 2002-09-11 | 2004-03-25 | Esplora GmbH c/o TU Darmstadt Institut für Biochemie | Verfahren zur Identifizierung BHS-spezifischer Proteine und Fragmente davon |
US20060182755A1 (en) * | 2002-09-11 | 2006-08-17 | Genentech, Inc. | Novel composition and methods for the treatment of psoriasis |
DE10254601A1 (de) * | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
EP1577322A4 (en) * | 2002-12-26 | 2006-01-25 | Takeda Pharmaceutical | NEW PROTEINS AND ITS USE |
US20060248603A1 (en) * | 2002-12-27 | 2006-11-02 | Applied Research Systems Ars Holding N.V. | Novel fibrillin-like polypeptides |
JP2006518193A (ja) * | 2003-01-16 | 2006-08-10 | ユニバーシティ オブ バージニア パテント ファウンデーション | 精子特異的リゾチーム様タンパク質 |
US7312197B2 (en) | 2003-02-24 | 2007-12-25 | University Of Maryland, Baltimore | Method of modifying glucose activity using polypeptides selectively expressed in fat tissue |
US20040185559A1 (en) | 2003-03-21 | 2004-09-23 | Isis Pharmaceuticals Inc. | Modulation of diacylglycerol acyltransferase 1 expression |
US7709610B2 (en) | 2003-05-08 | 2010-05-04 | Facet Biotech Corporation | Therapeutic use of anti-CS1 antibodies |
US20050025763A1 (en) | 2003-05-08 | 2005-02-03 | Protein Design Laboratories, Inc. | Therapeutic use of anti-CS1 antibodies |
DK2784084T4 (da) | 2003-07-08 | 2024-01-08 | Novartis Pharma Ag | Antagonist-antistoffer mod IL-17A/F heterologe polypeptider |
US7273610B2 (en) | 2003-08-14 | 2007-09-25 | Dyax Corp. | Endotheliase-2 ligands |
US7825235B2 (en) | 2003-08-18 | 2010-11-02 | Isis Pharmaceuticals, Inc. | Modulation of diacylglycerol acyltransferase 2 expression |
CA2551546A1 (en) * | 2003-12-24 | 2005-07-07 | Takeda Pharmaceutical Company Limited | Preventive/remedy for cancer |
DE102004024617A1 (de) | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
KR20070036089A (ko) | 2004-07-02 | 2007-04-02 | 제넨테크, 인크. | 비호지킨 림프종의 치료 방법 및 치료 조성물 |
EP1789070B1 (en) | 2004-08-03 | 2012-10-24 | Biogen Idec MA Inc. | Taj in neuronal function |
CA2574881C (en) | 2004-08-04 | 2013-01-08 | Amgen Inc. | Antibodies to dkk-1 |
US7544659B2 (en) | 2004-08-13 | 2009-06-09 | Genentech, Inc. | Promotion of axonal regeneration |
WO2006098887A2 (en) * | 2005-03-11 | 2006-09-21 | Genentech, Inc. | Gene disruptions, compositions and methods relating thereto |
EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
CA2630483C (en) | 2005-12-08 | 2015-05-19 | Medarex, Inc. | Human monoclonal antibodies to o8e |
WO2007107774A2 (en) * | 2006-03-22 | 2007-09-27 | Cartela R & D Ab | Integrin alpha-10 subunit as therapeutic target and diagnostic/prognostic marker for cancer |
JP2009536022A (ja) * | 2006-04-19 | 2009-10-08 | ジェネンテック・インコーポレーテッド | 新規の遺伝子破壊、それに関連する組成物および方法 |
ES2397661T3 (es) | 2006-08-04 | 2013-03-08 | Isis Pharmaceuticals, Inc. | Composiciones y sus usos dirigidos a la diacilglicerol aciltransferasa 1 |
WO2008026010A1 (en) | 2006-08-29 | 2008-03-06 | Oxford Genome Sciences (Uk) Ltd | Identification of protein associated with hepatocellular carcinoma, glioblastoma and lung cancer |
US8058014B2 (en) | 2006-09-29 | 2011-11-15 | University Of Maryland, Baltimore | Method of diagnosing or predicting disease states in a subject using omentin 1 and omentin 2 |
KR101508086B1 (ko) | 2008-05-05 | 2015-04-07 | 노비뮨 에스 에이 | 항-il-17a/il-17f 교차-반응성 항체 및 그의 사용 방법 |
CA3138282A1 (en) | 2008-06-02 | 2009-12-10 | Dana-Farber Cancer Institute, Inc. | Xbp1, cd138, and cs1 peptides |
US8420084B2 (en) | 2009-03-05 | 2013-04-16 | Medarex, Inc. | Fully human antibodies specific to CADM1 |
KR101811886B1 (ko) | 2009-05-05 | 2017-12-22 | 노비뮨 에스 에이 | 항―il―17f 항체 및 이의 사용 방법 |
WO2013167153A1 (en) | 2012-05-09 | 2013-11-14 | Ganymed Pharmaceuticals Ag | Antibodies useful in cancer diagnosis |
WO2013174404A1 (en) | 2012-05-23 | 2013-11-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
EP3919069A1 (en) | 2012-11-05 | 2021-12-08 | Dana-Farber Cancer Institute, Inc. | Xbp1, cd138, and cs1 peptides, pharmaceutical compositions that include the peptides, and methods of using such peptides and compositions |
CA3169263A1 (en) | 2012-11-13 | 2014-05-22 | Astellas Pharma Inc. | Agents for treatment of claudin expressing cancer diseases |
WO2014127785A1 (en) | 2013-02-20 | 2014-08-28 | Ganymed Pharmaceuticals Ag | Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
WO2014146672A1 (en) | 2013-03-18 | 2014-09-25 | Ganymed Pharmaceuticals Ag | Therapy involving antibodies against claudin 18.2 for treatment of cancer |
MY192997A (en) | 2015-07-10 | 2022-09-20 | Ionis Pharmaceuticals Inc | Modulators of diacyglycerol acyltransferase 2 (dgat2) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19817948A1 (de) * | 1998-04-17 | 1999-10-21 | Metagen Gesellschaft Fuer Genomforschung Mbh | Menschliche Nukleinsäuresequenzen aus Endometrium-Tumor |
IL139686A0 (en) * | 1998-06-02 | 2002-02-10 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
CA2383592A1 (en) * | 1999-03-31 | 2000-10-05 | Curagen Corporation | 2384891 acids including open reading frames encoding polypeptides; orfx |
ATE478145T1 (de) * | 1999-06-02 | 2010-09-15 | Genentech Inc | Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren |
WO2001040269A2 (en) * | 1999-11-30 | 2001-06-07 | Corixa Corporation | Compositions and methods for therapy and diagnosis of breast cancer |
EP1572987A4 (en) * | 2000-02-03 | 2005-11-30 | Nuvelo Inc | NUCLEIC ACIDS AND POLYPEPTIDES |
AU2001270118A1 (en) * | 2000-08-24 | 2002-03-04 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
-
2000
- 2000-11-29 AU AU6802801A patent/AU6802801A/xx active Pending
-
2001
- 2001-02-28 CA CA002534018A patent/CA2534018A1/en not_active Abandoned
- 2001-02-28 CA CA002531917A patent/CA2531917A1/en not_active Abandoned
- 2001-02-28 WO PCT/US2001/006520 patent/WO2001068848A2/en active Application Filing
- 2001-02-28 CA CA002539214A patent/CA2539214A1/en not_active Abandoned
- 2001-02-28 JP JP2001567332A patent/JP2004508805A/ja not_active Withdrawn
- 2001-02-28 CA CA002401448A patent/CA2401448A1/en not_active Abandoned
- 2001-02-28 EP EP01945919A patent/EP1259614A2/en not_active Withdrawn
- 2001-02-28 CA CA002534186A patent/CA2534186A1/en not_active Abandoned
- 2001-02-28 CA CA002533903A patent/CA2533903A1/en not_active Abandoned
- 2001-02-28 CA CA002534391A patent/CA2534391A1/en not_active Abandoned
- 2001-02-28 AU AU2001268028A patent/AU2001268028A1/en not_active Abandoned
- 2001-02-28 CA CA002533991A patent/CA2533991A1/en not_active Abandoned
- 2001-02-28 CA CA002534030A patent/CA2534030A1/en not_active Abandoned
- 2001-02-28 CA CA002533831A patent/CA2533831A1/en not_active Abandoned
-
2005
- 2005-08-15 JP JP2005264294A patent/JP2006081548A/ja not_active Withdrawn
-
2008
- 2008-06-12 JP JP2008153789A patent/JP2008301822A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2533991A1 (en) | 2001-09-20 |
CA2531917A1 (en) | 2001-09-20 |
CA2401448A1 (en) | 2001-09-20 |
JP2008301822A (ja) | 2008-12-18 |
CA2534030A1 (en) | 2001-09-20 |
CA2533903A1 (en) | 2001-09-20 |
JP2004508805A (ja) | 2004-03-25 |
CA2534391A1 (en) | 2001-09-20 |
AU2001268028A1 (en) | 2001-09-24 |
JP2006081548A (ja) | 2006-03-30 |
CA2533831A1 (en) | 2001-09-20 |
CA2539214A1 (en) | 2001-09-20 |
CA2534018A1 (en) | 2001-09-20 |
WO2001068848A3 (en) | 2002-08-29 |
WO2001068848A2 (en) | 2001-09-20 |
CA2534186A1 (en) | 2001-09-20 |
EP1259614A2 (en) | 2002-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6802801A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU7315001A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU6531101A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU1661002A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
IL139686A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
IL201001A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU7573000A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU2055401A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU2883700A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU2883900A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
IL141535A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU2002368010A8 (en) | Novel nucleic acids and secreted polypeptides | |
EP1173456A4 (en) | SECRETED PROTEINS AND NUCLEIC ACIDS ENCODING THEM | |
AU2002367815A8 (en) | Novel nucleic acids and secreted polypeptides | |
AU2001249394A1 (en) | Secreted proteins and polynucleotides encoding them | |
AU2001239889A1 (en) | Polypeptides and nucleic acids encoding same | |
KR100514265B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
KR100532172B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
KR100498658B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
KR100528420B1 (en) | Secreted and Transmembrane polypeptides and Nucleic Acids Encoding the Same | |
AU4587101A (en) | Novel human secreted proteins and polynucleotides encoding the same | |
AU2001234896A1 (en) | Novel polypeptides and nucleic acids encoding same | |
IL142673A0 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
AU5152700A (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
IL137823A0 (en) | Novel polypeptides and nucleic acids encoding the same |